Filter
219
Filtered Results: 219
Text search:
antimalarial
Pharmaceuticals
Featured
Recommendations
24
New Publications
83
Language
Document type
No document type
113
Studies & Reports
41
Guidelines
31
Manuals
11
Strategic & Response Plan
8
Fact sheets
7
Training Material
4
Situation Updates
2
Resource Platforms
1
Infographics
1
Countries / Regions
Ethiopia
16
Uganda
14
Kenya
11
Malawi
8
Tanzania
8
Sierra Leone
7
Liberia
7
Ghana
6
Rwanda
5
Nigeria
5
Zimbabwe
5
Zambia
5
Cameroon
4
Senegal
4
Burkina Faso
4
Philippines
4
India
4
Africa
3
Cambodia
3
South–East Asia Region
3
Nepal
2
Thailand
2
Mozambique
2
Global
2
Latin America and the Carribbean
2
Congo, Democratic Republic of
2
East and Southern Africa
2
South Africa
2
Vietnam
2
Papua New Guinea
2
Namibia
2
Lesotho
1
Benin
1
China
1
Laos
1
Guinea
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Turkmenistan
1
Lebanon
1
Bangladesh
1
Central African Republic
1
Libya
1
Botswana
1
Somalia
1
Myanmar / Burma
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
126
Clinical Guidelines
16
Key Resources
11
Pharmacy & Technologies
8
Women & Child Health
7
Public Health
4
Capacity Building
1
Toolboxes
Pharmacy
34
AMR
31
Rapid Response
3
Ebola & Marburg
3
COVID-19
3
NTDs
3
Health Financing Toolbox
3
TB
2
Planetary Health
2
Global Health Education
2
Natural Hazards
1
HIV
1
Caregiver
1
Supplement to the Healthcare Waste Management Toolkit for Global Fund
Practitioners and Policy Makers
SITUATION ANALYSIS AND RECOMMENDATIONS
The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the health sector policy. Indeed, medicines play an important role in protecting, maintaining and restoring th...
This updated glossary for malaria aims to improve communication and mutual understanding within the scientific community, as well as with funding agencies, public health officials responsible for malaria programmes, and policy-makers in malaria-endemic countries
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
Healthcare Waste Management Toolkit for Global Fund Practitioners and Policy Makers. Part B
Nat Med (2021). https://doi.org/10.1038/s41591-021-01381-y
Fourth Edition
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
Conducted November 2011 to February 2012: Summary Report
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-increasing range of infections caused by bacteria, para...
